Biao Yan

Chief Executive Officer en ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. .

42 años

Health Technology

Consumer Services

Perfil

Biao Yan is currently the Chairman & General Manager at Zhejiang Shapuaisi Pharmaceutical Co. Ltd.
and Chairman at Shapuaisi Qiangshen Pharma Co., Ltd.
He completed his undergraduate degree at Shanghai Jiao Tong University.

Cargos activos de Biao Yan

Empresas	Cargo	Inicio
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.	Chief Executive Officer	10/05/2021
Shapuaisi Qiangshen Pharma Co., Ltd. Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The private company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million.	Chairman	-

Todos los cargos activos de Biao Yan

Formación de Biao Yan.

Shanghai Jiao Tong University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Biao Yan.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.	Health Technology

Empresas privadas	1
Shapuaisi Qiangshen Pharma Co., Ltd. Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The private company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million.	Health Technology